Genesystem Co., Ltd. (KOSDAQ:363250)

Genesystem Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	36,411	59,357	65,169	58,004
Market Cap Growth	19.69%	-8.92%	12.35%	-
Enterprise Value	37,493	56,608	42,775	-
Last Close Price	5170.00	8440.00	9330.00	8370.00
Forward PE	-	14.85	14.85	-
PS Ratio	32.05	49.15	72.65	15.88
PB Ratio	1.83	2.71	2.12	1.65
P/TBV Ratio	3.37	4.79	3.28	1.69
EV/Sales Ratio	33.01	46.87	47.69	-
Debt / Equity Ratio	0.21	0.19	0.15	0.12
Asset Turnover	0.04	0.04	0.02	-
Inventory Turnover	0.97	1.20	0.79	-
Quick Ratio	2.22	3.08	5.99	13.76
Current Ratio	3.23	3.93	8.65	15.50
Return on Equity (ROE)	-37.80%	-36.25%	-24.50%	-
Return on Assets (ROA)	-18.55%	-18.37%	-14.80%	-
Return on Capital (ROIC)	-21.06%	-20.67%	-15.94%	-
Earnings Yield	-23.41%	-15.02%	-12.15%	-15.51%
FCF Yield	-20.49%	-12.80%	-12.54%	-11.47%
Buyback Yield / Dilution	2.33%	1.50%	-0.69%	-

Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.